Clinical Trial Update: Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial). [Phase 2]

View source ↗

Summary

A multicenter Phase II trial evaluating bevacizumab with pemetrexed and cisplatin or erlotinib with bevacizumab in stage IV non-small cell lung cancer, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Erlotinib hydrochloride (Erlotinib)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED